CG Oncology (CGON) EBITDA (2023 - 2026)
CG Oncology posted quarterly EBITDA of -$66.4 million for Q1 2026, down 57.3% year-on-year from -$155.5 million in Q1 2025, and down 36.32% on a QoQ basis from -$48.7 million in Q4 2025.
CG Oncology (CGON) has 4 years of EBITDA data on file, last reported at -$66.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA fell 57.3% year-over-year to -$66.4 million; the trailing twelve-month figure through Mar 2026 stood at -$215.0 million (down 59.94% YoY), and the FY2025 full-year result was -$190.8 million, down 66.37% from the prior year.
- EBITDA for Q1 2026 stood at -$66.4 million, down from -$48.7 million in the prior quarter.
- Across five years, EBITDA topped out at -$9.7 million in Q1 2023 and bottomed at -$66.4 million in Q1 2026.
- The 4-year median for EBITDA is -$28.3 million (2024), against an average of -$32.9 million.
- The widest annual swing landed in 2024, when EBITDA sank 131.14%; it then dropped 27.99% in 2025.
- A 4-year view of EBITDA shows it stood at -$19.4 million in 2023, then tumbled by 96.58% to -$38.0 million in 2024, then declined by 27.99% to -$48.7 million in 2025, then slumped by 36.32% to -$66.4 million in 2026.
- The last three EBITDA figures came in at -$66.4 million (Q1 2026), -$48.7 million (Q4 2025), and -$51.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 661.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 201.19 Mn |
| 10 | CG Oncology | 5.01 Bn | 5.01 Bn | -1.88 Mn | -66.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.39 Mn |
| Dec 31, 2025 | -48.70 Mn |
| Sep 30, 2025 | -51.13 Mn |
| Jun 30, 2025 | -48.74 Mn |
| Mar 31, 2025 | -42.20 Mn |
| Dec 31, 2024 | -38.05 Mn |
| Sep 30, 2024 | -28.30 Mn |
| Jun 30, 2024 | -25.85 Mn |
| Mar 31, 2024 | -22.47 Mn |
| Dec 31, 2023 | -19.36 Mn |
| Sep 30, 2023 | -14.04 Mn |
| Jun 30, 2023 | -12.33 Mn |
| Mar 31, 2023 | -9.72 Mn |